Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Top 10 therapeutic classes by global pharmaceutical sales in 2016 (in billion U.S. dollars)

Exclusive Premium Statistic

Top therapeutic classes by global pharmaceutical sales 2016 This statistic depicts the top 10 therapeutic classes by global pharmaceutical sales in 2016. In that year, the global pharmaceutical industry generated a total revenue of some 37 billion U.S. dollars through mental health drug spending.
Top therapeutic classes and drugs

Oncologics, pain therapy, and anti-diabetics are among the top global pharmaceuticals based on revenues, generating 75 billion U.S. dollars, 68 billion U.S. dollars, and 66 billion U.S. dollars, respectively, in 2016. In oncologic developments, drugs for non-small cell lung cancer and breast cancer were among the leading diseases in therapeutic drug development. On the other hand, Cymbalta was one of the top serotonin-norepinephrine reuptake inhibitors (SNRIs) in the United States, accounting over 40 percent of the market share. Cymbalta is manufactured by Eli Lilly and used to treat major depressive disorder and generalized anxiety disorder.

One of Bristol-Myers Squibb’s most profitable medications is Abilify, a neurology product that generated revenue of 5.8 billion U.S. dollars in the United States in 2015. Aripiprazole, marketed as Abilify, is used for the treatment of schizophrenia, bipolar disorder, and major depressive disorder, among other disorders. Bristol-Myers Squibb’s neuroscience program focuses on the development of therapeutic regimens for disorders that impact the brain and nervous systems. Some of the company’s other therapeutic areas of focus include cardiovascular, immunoscience, and virology.
Show more
Exclusive Premium statistic

Get a Premium Account for unrestrained access.
Benefits of our Premium membership:

  • Access to all Premium statistics
  • Download as XLS, PNG and PDF
  • Detailed source and background information
Premium Account
$49 per month*
(billed annually)
*Single license

Access to this and all other statistics on 80,000 topics from

$588 / Year

View price details

Sales in billion U.S. dollars
--
--
--
--
--
--
--
--
--
--
Sales in billion U.S. dollars
--
--
--
--
--
--
--
--
--
--
Exclusive Premium statistic

Get a Premium Account for unrestrained access.
Benefits of our Premium membership:

  • Access to all Premium statistics
  • Download as XLS, PNG and PDF
  • Detailed source and background information
Premium Account
$49 per month*
(billed annually)
*Single license

Access to this and all other statistics on 80,000 topics from

$588 / Year

View price details

© Statista 2018

Download Settings Share
Chart type
Datalabels
Share on Social Media
Download started
Please be patient - this may take a moment
Description Source More information
This statistic depicts the top 10 therapeutic classes by global pharmaceutical sales in 2016. In that year, the global pharmaceutical industry generated a total revenue of some 37 billion U.S. dollars through mental health drug spending.
Top therapeutic classes and drugs

Oncologics, pain therapy, and anti-diabetics are among the top global pharmaceuticals based on revenues, generating 75 billion U.S. dollars, 68 billion U.S. dollars, and 66 billion U.S. dollars, respectively, in 2016. In oncologic developments, drugs for non-small cell lung cancer and breast cancer were among the leading diseases in therapeutic drug development. On the other hand, Cymbalta was one of the top serotonin-norepinephrine reuptake inhibitors (SNRIs) in the United States, accounting over 40 percent of the market share. Cymbalta is manufactured by Eli Lilly and used to treat major depressive disorder and generalized anxiety disorder.

One of Bristol-Myers Squibb’s most profitable medications is Abilify, a neurology product that generated revenue of 5.8 billion U.S. dollars in the United States in 2015. Aripiprazole, marketed as Abilify, is used for the treatment of schizophrenia, bipolar disorder, and major depressive disorder, among other disorders. Bristol-Myers Squibb’s neuroscience program focuses on the development of therapeutic regimens for disorders that impact the brain and nervous systems. Some of the company’s other therapeutic areas of focus include cardiovascular, immunoscience, and virology.
Show more
Release date
December 2016
Region
Worldwide
Survey time period
2016
Supplementary notes
The statistic includes 8 developed and 6 pharmerging countries: U.S., EU5, Japan, Canada, China, Brazil Russia, India, Turkey, Mexico.

Statista Accounts: Access All Statistics. Starting from $588 / Year

Statistics on "Global pharmaceutical industry"

  • Overview
The most important statistics
  • Companies and products
The most important statistics
  • Top companies by revenue
  • R&D, patents, new entities
  • Outlook
The most important statistics

Related Studies: Available to Download in PDF or PPTX Format

Top pharmaceutical drugs

All Information
in one Presentation

Top pharmaceutical drugs

Everything On "Top pharmaceutical drugs" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.

Other Reports & Dossiers

Statista for Your Company: The Research and Analysis Tool

  • Product Film
  • Statistics
  • Downloads

Our Premium Statistics - facts for your business

Currently, Statista provides more than 1 million statistics.
93 percent (all Premium content) are exclusively accessible via our professional accounts.

Unlimited access

As a Statista Premium customer, you receive unlimited access to all statistics at all times. Including downloads of data in the most common formats (XLS, PDF & PNG). Create relevant and significant statistics in no time.

You are in good company

Further Content: Statistics, Studies, and Topic Pages

Our Business Solutions: Save Time and Money

only

$588*

per year
Your advantages
  • Full access to all our statistics
  • Download as XLS, PDF & PNG
  • Relevant data: complete source information
All functions of our platform illustrated face-to-face
  • Learn how Statista supports your company
  • Extensive tour across the whole portal
  • Personal guidance by our support team
The knowledge database for your company
  • All functions of the Premium Account
  • Access to dossiers, forecasts and studies
  • Access to our international database
  • Publishing rights and other exclusive functions

Statistics on the topic

Topics

About Statista

Learn more about how Statista can support your business.

Request webinar